ASSERTIO THERAPEUTICS, INC. Finite-Lived Intangible Assets, Gross
ASSERTIO THERAPEUTICS, INC. had Finite-Lived Intangible Assets, Gross of $908.80 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2020-05-11
- 2020-03-31: Finite-Lived Intangible Assets, Gross $908.80M.
- 2019-12-31: Finite-Lived Intangible Assets, Gross $1.10B.
- 2019-09-30: Finite-Lived Intangible Assets, Gross $1.10B.
- 2019-06-30: Finite-Lived Intangible Assets, Gross $1.10B.
| Period end | Finite-Lived Intangible Assets, Gross | Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2020-03-31 | $908.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.10B 10-Q · filed 2020-05-11 | |
| 2019-09-30 | $1.10B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.10B 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.10B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.10B 10-K · filed 2020-03-10 | |
| 2018-09-30 | $1.10B 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.10B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.10B 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.10B 10-K · filed 2019-03-11 | |
| 2017-09-30 | $1.11B 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.11B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.11B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.11B 10-K · filed 2018-03-01 | |
| 2016-09-30 | $1.11B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.11B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $1.11B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $1.11B 10-K · filed 2017-02-24 | $1.11B 10-K · filed 2016-02-26 |
| 2015-09-30 | $1.11B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.11B 10-Q · filed 2015-08-03 | |
| 2014-12-31 | $89.09M 10-K · filed 2016-02-26 |